Inogen Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
Inogen, Inc. (NASDAQ: INGN), a medical technology firm specializing in respiratory products, announced participation in the 40th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Inogen’s President and CEO,
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211215005005/en/
Investor and Media Contacts
Inogen-SVC@sardverb.com
(312) 895-4700
Source: